Watch CNBC's full interview with Novo Nordisk CEO Mike Doustdar

Mike Doustdar, new CEO of Ozempic maker, Novo Nordisk discusses his strategy for the future of the company. Trump demands ...

'Not been pretty': Novo Nordisk faces rare shareholder rebuke over board shake-up

Novo Nordisk faces a shareholder backlash on Friday as the Danish drugmaker's minority investors prepare a protest vote ...

Pfizer adquiere Metsea, desarrolladora de fármacos contra la obesidad, tras puja con Novo Nordisk

El gigante farmacéutico estadounidense Pfizer firmó un acuerdo para adquirir Metsera Inc., la empresa desarrolladora de ...
STAT

Novo Nordisk to cut 11% of workforce as it seeks to regain competitive edge

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Novo Nordisk, under new leadership and in need of a boost, said ...

Novo’s New Chairman Urged to Curb Risk After Metsera Drama

Investors are meeting on Friday to elect Lars Rebien Sorensen to lead the supervisory board less than a week after Novo lost ...